A fully-loaded product pipeline in various stages of clinical development, Nobel Prize-winning advisors, partnerships with the University of Oxford and Yale University — and much more. At the heart of each one of our initiatives is a commitment to rigorous scientific research.
Product Pipeline
Our current pipeline includes preclinical and clinical trials for skin, microbiome, muscle, cognition, UV damage, menopausal syndromes, and circadian rhythm. Beyond Basis, Matter, Format, Signal, Mosaic, and Index, we are working with our scientific advisors and university partners to identify promising new research and innovative compounds.
These compounds are all tested for safety and efficacy in placebo-controlled human trials before coming to market.
As you can see from our preclinical studies and clinical trials outlined below, there’s a lot happening behind the scenes at Elysium — and a lot to look forward to.